Sequenom (SQNM) News Today → The Gold Grab of the Century (From Colonial Metals) (Ad) Free SQNM Stock Alerts Notice: This company has been marked as potentially delisted and may not be actively trading. Add Share Share HeadlinesStock Analysis All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadline5 Biotech Stocks Under $10 Set to Soarthestreet.com - September 9 at 6:32 AMSequenom Fallout Hits Hedge Fundsthestreet.com - July 23 at 12:49 AMLatest Markets Newsreuters.com - May 18 at 9:53 AMSequenom Still Very Good, Just No Longer Perfectthestreet.com - February 27 at 9:58 PMPast Sequenom Exec Charged with Lying by SECthestreet.com - January 7 at 2:05 PMJUNO DIAGNOSTICS STRENGTHENS THE ORGANIZATION WITH APPOINTMENT OF GINA GRAYUM TO COMMERCIAL LEADERSHIP TEAM - StreetInsider.comstreetinsider.com - October 19 at 5:36 PMJUNO DIAGNOSTICS STRENGTHENS THE ORGANIZATION WITH APPOINTMENT OF GINA GRAYUM TO COMMERCIAL LEADERSHIP TEAM - PR Newswireprnewswire.com - October 18 at 8:50 AMPrenatal and Newborn Genetic Testing Market to hit US$ 12.70 Billion by 2030 | Exclusive Report by Growth Plus Reports - GlobeNewswireglobenewswire.com - October 12 at 7:58 AMViral Antigens Market to Reach US$ 0.292 billion by 2030 Size, Shares, Forecasts, and Trends Analysis Report with COVID-19 Impact by Growth Plus Reports - GlobeNewswireglobenewswire.com - October 10 at 9:35 AMInvitae: Losses & Debt Suggest Bearish Sentiment Is Deserved - Seeking Alphaseekingalpha.com - September 23 at 3:09 AMWorld Non-Invasive Prenatal Testing (NIPT) Pipeline Market Report 2022: Comparative Analysis at Various Stages of Development and Information on Clinical Trials in Progress - ResearchAndMarkets.com - Business Wirebusinesswire.com - September 19 at 11:21 AMAnsa Bio Appoints Lorna Neilson, Ph.D. as Chief Business Officer - Business Wirebusinesswire.com - September 7 at 5:53 PMThe Worldwide Carrier Screening Industry is Expected to Reach $3.64 Billion by 2030 - GlobeNewswireglobenewswire.com - July 1 at 6:26 PMThe Worldwide Carrier Screening Industry is Expected to Reach $3.64 Billion by 2030 - Yahoo Finance UKuk.finance.yahoo.com - June 29 at 6:24 PMNew Analysis from Global Industry Analysts Reveals Steady Growth for Genotyping, with the Market to Reach $39.9 Billion Worldwide by 2026 - PR Newswireprnewswire.com - June 23 at 5:27 PMNew Analysis from Global Industry Analysts Reveals Steady Growth for Genotyping, with the Market to Reach $39.9 Billion Worldwide by 2026 - Yahoo Financefinance.yahoo.com - June 23 at 8:32 AMLaboratory Corp: 15% Reward Asymmetry Under-Reflected, Seeking Exit At $280 Per Share - Seeking Alphaseekingalpha.com - June 5 at 4:30 AMAadi Bioscience Appoints Marcy Graham Senior Vice President Investor Relations and Corporate Communications - Yahoo Financefinance.yahoo.com - May 31 at 10:22 AMFed. Circ. Says LabCorp Missed Chance To Move Patent Row - Law360law360.com - May 13 at 3:45 AMIDEAYA Biosciences Appoints Catherine Mackey, Ph.D., to its Board of Directors - PR Newswireprnewswire.com - April 6 at 6:29 AMGlobal Non-invasive Prenatal Testing Market Report 2022: By Type, End User, Instruments, Consumables and Application - ResearchAndMarkets.com - Business Wirebusinesswire.com - March 9 at 7:53 AMAmbrx Biopharma Inc. Appoints Paul Maier to Board of Directors and as Chair of the Audit Committee - Yahoo Financefinance.yahoo.com - February 7 at 4:42 PMAmbrx Biopharma Inc. Appoints Paul Maier to Board of Directors and as Chair of the Audit Committee - Business Wirebusinesswire.com - February 7 at 8:31 AMAmbrx Biopharma (AMAM) Appoints Paul Maier to Board of Directors and as Chair of the Audit Committee - StreetInsider.comstreetinsider.com - February 7 at 8:31 AMGlobal Genotyping Assay Market to Reach Over $40.0 Billion by 2028 - GlobeNewswireglobenewswire.com - January 26 at 1:34 PMFeganScott Announces Investigation into Prenatal Testing Options Revealing Flawed Genetic Results - Yahoo Financefinance.yahoo.com - January 18 at 2:43 AMCorrections: Jan. 8, 2022 - The New York Timesnytimes.com - January 8 at 2:20 AMSmall Pharma Strengthens Board With Appointment of Paul Maier as Independent Director - StreetInsider.comstreetinsider.com - November 20 at 10:35 AMSmall Pharma Strengthens Board With Appointment of Paul Maier as Independent Director - Yahoo Finance UKuk.finance.yahoo.com - November 18 at 6:00 PMPreterm Birth & PROM Testing Market Research Report by Type, by End-user, by Region - Global Forecast to 2026 - Cumulative Impact of COVID-19 - Yahoo Financefinance.yahoo.com - November 10 at 6:14 AMAdhera Therapeutics Announces Appointment of Dr. Zahed Subhan to Board of Directors - Yahoo Financefinance.yahoo.com - November 9 at 7:40 AMSonendo Appoints Three New Members to Board of Directors - Yahoo Financefinance.yahoo.com - November 3 at 7:52 PMMDxHealth: Providing Personalizable Molecular Diagnostic Information - Seeking Alphaseekingalpha.com - October 16 at 9:00 AM3 Patent Eligibility Reform Ideas Add Clarity But Bring Risks - Law360law360.com - September 28 at 11:45 PMInterview With Dr. Wang Jian - Forbesforbes.com - August 11 at 7:07 AMGlobal Nanopore Sequencing Market, By Product, By Nucleotide Sequenced, By Type, By Type of Nanopore, By Application, By End User, By Region, Competition Forecast & Opportunities, 2026 - Yahoo Financefinance.yahoo.com - August 10 at 7:41 AM Get Sequenom News Delivered to You Automatically Sign up to receive the latest news and ratings for SQNM and its competitors with MarketBeat's FREE daily newsletter. Email Address The World's First "$20 Trillion Drug?" (Ad)One small biotech holds the key to a revolution in treating Alzheimer's disease. Jeff Bezos, Goldman Sachs & Big Pharma giants have invested billions into this unknown biotech. Our research proves that anyone who gets in today could see gains as high as 113,000%! Get the name of the stock here >>> SQNM Media Mentions By Week SQNM Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. SQNM News Sentiment▼0.000.40▲Average News Sentiment SQNM News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. SQNM Articles This Week▼00▲SQNM Articles Average Week Get Sequenom News Delivered to You Automatically Sign up to receive the latest news and ratings for SQNM and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:SQNM) was last updated on 4/26/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThe Best AI Stock to Own in the World Today is Trading for Just $25Banyan Hill PublishingRed Alert: Your Money's Disappearance Act - Banks' Greed Unleashed!Priority GoldThese AI trades triggered this morning (545% return)Prosper Trading AcademyThe A.I. story nobody is telling you (Read ASAP)TradeSmithDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsTrump is sounding the alarmPreserve GoldFed launches fourth dollar overhaulStansberry Research Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Sequenom Inc Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
